Table 1 Demographic data and status of anti-PT IgG antibodies in studied subjects
Subgroup | n | Mean of anti-PT IgG and 95% CI (IU/mL) | Pa | Number of subjects (%) in concentrations of anti-PT IgG | Pc | ||
|---|---|---|---|---|---|---|---|
<30IU/mL | ≥30IU/mL | ≥100IU/mL | |||||
Total | 1313 | 14.21(12.29-16.13) | 1196(91.09%) | 93(7.08%) | 24(1.83%) | ||
Home location | |||||||
City | 660 | 14.51(11.43-17.58) | 0.76 | 609(92.27%) | 51(7.73%) | 13(1.97%) | 0.18 |
County | 653 | 13.92(11.62-16.23) | 587(89.89%) | 66(10.11%) | 11(1.68%) | ||
Gender | |||||||
Male | 654 | 15.09(12.43-17.73) | 0.37 | 589(90.06%) | 65(9.94%) | 15(2.29%) | 0.14 |
Female | 659 | 13.35(10.57-16.12) | 607(92.11%) | 52(7.89%) | 9(1.36%) | ||
Age (average age) | |||||||
0-2(1.94) | 80 | 10.91(7.01-14.82) | 0.55 | 72(90%) | 8(10.0%) | 1(1.25%) | 0.44 |
3-4(4.2) | 79 | 9.95(5.74-14.17) | 75(94.94%) | 4(5.06%) | 1(1.26%) | ||
5-6(5.8) | 79 | 10.80(4.95-16.65) | 75(94.94%) | 4(5.06%) | 1(1.26%) | ||
7-12(9.4) | 61 | 9.45(6.04-12.86) | 0.03b | 57(93.44%) | 4(6.56%) | 0(0) | |
13-19(17.4) | 175 | 18.44(11.08-25.81) | 155(88.57%) | 20(11.43%) | 6(3.43%) | ||
20-30(23.8) | 256 | 15.70(9.89-21.5) | 237(92.58%) | 19(7.42%) | 6(2.34%) | ||
31-40(35.7) | 204 | 13.60(9.85-17.34) | 188(92.16%) | 16(7.84%) | 3(1.47%) | ||
41-50(46.0) | 173 | 15.42(9.34-21.51) | 153(88.44%) | 20(11.56%) | 3(1.73%) | ||
> 51(64.5) | 206 | 14.02(10.94-17.10) | 184(89.32%) | 22(10.68%) | 3(1.46%) | ||